To the surprise of all the treating cardiologists, the patient presented with an ejection fraction of 5%, which improved to 55% after support with Impella RP® and Impella CP®.
In the era of increasing healthcare costs, the cost-effectiveness of traditional versus emerging technologies is an ongoing consideration when evaluating long-term outcomes.
Jo Kajewski, global Impella® trainer, describes the soft buttons, waveforms, and other information displayed on the AIC placement screen when a patient is on Impella support.
Jo Kajewski, advanced Impella trainer, discusses how to assess the Impella access site, change dressings, and help prevent access site bleeding to improve patient outcomes.
This FAQ explains how the conclusion of Amin et al. conflicts with more robust, previously published, FDA-audited, peer-reviewed, real-world studies and RCTs.
Jo Kajewski, advanced Impella trainer, discusses how Impella should appear on baseline echo and steps for repositioning Impella if a positioning alarm occur.
Navin K. Kapur, MD, FACC, FSCAI, FAHA, discusses how acute cardiac unloading limits infarct scar formation in the context of the DTU-STEMI Pilot trial and Pivotal trial.
Navin Kapur, MD, uses Impella RP to effectively manage univentricular shock in a patient with right ventricular failure.
NPS-1674
This information is intended for use by customers, patients, and healthcare professionals in [region] only. We recognize that the Internet is a global communications medium; however, laws, regulatory requirements, and product information for medical products can vary from country to country. The product information included here may not be appropriate for use outside [region], and the information from other sites you visit may not be appropriate for use in [region].
The Protected PCI community
is now on HeartRecovery.com
Providing education and training to help health care professionals
recover hearts, oxygenate the body and save lives.
